Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Hamad Alam
Rectal Adenocarcinoma
New Delhi
Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…
Shilipi
Acute Recurrent Pancreatitis
Kotdwar, Uttarakhand.
Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …
Anurag Goyal
Investment Banker
New Delhi
Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…
Sumit Kumar
Pancreas Divisum with secondary Chronic Pancreatitis
Dehradun, Uttarakhand
Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…
Aviral Saxena
Chronic Pancreatitis with Secondary Diabetes
Dehradun, Uttarakhand
Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …
Rajeev Sharma
Chronic Pancreatitis
Dehradun, Uttarakhand
Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Demographic Pattern of Pancreatitis Patients in India – A Hospital-based Study
A hospital-based study on 2,050 pancreatitis patients across India found that 83% were male, with an average age of 24 years, and 75% aged between 19–45. Alcohol use was reported by 33.6% and tobacco by 18.4%, while genetic and gallstone-related causes accounted for 8.8% and 5% respectively. The findings suggest emerging lifestyle and regional risk factors, but broader studies are needed for definitive insights.
Impact Evaluation of Ayurvedic Treatment Protocol on Three HundredNineteen Cases of Different Variants of Pancreatitis
Pancreatitis, affecting the pancreas' function, causes symptoms like pain, nausea, and weight loss. Conventional treatments are limited, prompting many to seek alternative medicine. A North India Ayurvedic clinic successfully treated 319 cases of Recurrent Acute/Chronic Pancreatitis using a specialized Ayurvedic Treatment Protocol (ATP), including the formulation Amar. This treatment improved weight and reduced attack frequency without side effects. Ongoing research is exploring its potential.
Immunomodulatory Effects of a Herbo-Mineral Ayurvedic Formulation in Experimental Models
IMMBO, a herbo-mineral Ayurvedic formulation, shows promise as an immune-modulator in immunosuppressed rats. It enhances immunity, blocks histamine release, and modulates key molecules like TNF-α and NF-κB, offering potential for allergic and immune-related disorders.
Ayurvedic treatment protocol in the management of pancreatitis: A nonrandomized observational study
A North Indian clinic treated 1750 recurrent pancreatitis patients (1997–2023) with an ayurvedic Herbo-Mineral Formulation (HMF). Among 916 completing 1-year treatment, attacks reduced by 93%, hospitalizations by 97%, with no adverse effects. Long-term remission supports further clinical trials.
Management of multi-relapsed chronic pancreatitis through Rasaushadhis: A case study
Chronic pancreatitis causes irreversible pancreatic damage with limited treatment success and significant mortality. This case highlights a patient managed with Ayurveda, achieving nine years symptom-free and no disease progression.
Case studies on prophylactic ayurvedic therapy in migraine patients
Ayurvedic treatment has shown effectiveness in managing migraines. A protocol (ATP) with herbo-mineral formulations, regular meals, and sleep reduced migraine frequency and intensity in a study of nine patients. Five reported significant improvement after 120 days, with no serious side effects. Ongoing research is further validating the findings.